NISEC Archives

12 Sep COVID-19 Vaccine Janssen update – Second fatal case of Guillain-Barré syndrome

Posted at 16:25h in News & Updates, Press Releases

Pretoria, 12 September 2022 - On the 04th of August 2022, SAHPRA issued a media statement relating to the first fatal case of GBS following vaccination with COVID-19 Vaccine Janssen. Recently, SAHPRA has been informed of a second fatal case of Guillain-Barré syndrome (GBS) following...

Artem Podrez via Pexels

04 Aug Update on COVID-19 Vaccine Janssen – Guillain-Barré syndrome

Posted at 09:57h in News & Updates, Press Releases

04 August 2022 On 31 March 2021, SAHPRA approved the use of the COVID-19 Vaccine Janssen for individuals 18 years of age and older as a single primary vaccination dose. COVID-19 Vaccine Janssen was later approved as a single booster dose given at least two months...

NISEC Tag

12 Sep COVID-19 Vaccine Janssen update – Second fatal case of Guillain-Barré syndrome

04 Aug Update on COVID-19 Vaccine Janssen – Guillain-Barré syndrome

CONTACT US

Quick Menu

I want to..

Newsletter Subscription

Follow us